4.725 USD
+0.1 (+2.27%)
Overall DHC gets a fundamental rating of 2 out of 10. We evaluated DHC against 128 industry peers in the Diversified REITs industry. Both the profitability and financial health of DHC have multiple concerns. DHC does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year DHC has reported negative net income.
In the past year DHC had a positive cash flow from operations.
DHC had negative earnings in 4 of the past 5 years.
In multiple years DHC reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of DHC (-7.52%) is worse than 85.94% of its industry peers.
Looking at the Return On Equity, with a value of -20.85%, DHC is doing worse than 82.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.52% | ||
| ROE | -20.85% | ||
| ROIC | N/A |
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DHC has a worse Gross Margin (17.58%) than 92.97% of its industry peers.
DHC's Gross Margin has declined in the last couple of years.
DHC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.58% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
2. Health
2.1 Basic Checks
DHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DHC has been increased compared to 1 year ago.
DHC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DHC is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -0.31, we must say that DHC is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of DHC (-0.31) is worse than 79.69% of its industry peers.
A Debt/Equity ratio of 1.61 is on the high side and indicates that DHC has dependencies on debt financing.
DHC has a worse Debt to Equity ratio (1.61) than 60.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.61 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.31 |
ROIC/WACCN/A
WACC6.18%
2.3 Liquidity
A Current Ratio of 6.66 indicates that DHC has no problem at all paying its short term obligations.
DHC has a Current ratio of 6.66. This is amongst the best in the industry. DHC outperforms 97.66% of its industry peers.
DHC has a Quick Ratio of 6.66. This indicates that DHC is financially healthy and has no problem in meeting its short term obligations.
DHC has a better Quick ratio (6.66) than 97.66% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.66 | ||
| Quick Ratio | 6.66 |
3. Growth
3.1 Past
DHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.32%.
Looking at the last year, DHC shows a small growth in Revenue. The Revenue has grown by 4.10% in the last year.
The Revenue has been growing slightly by 7.53% on average over the past years.
EPS 1Y (TTM)-22.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3500%
Revenue 1Y (TTM)4.1%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%4.03%
3.2 Future
The Earnings Per Share is expected to grow by 17.25% on average over the next years. This is quite good.
DHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.37% yearly.
EPS Next Y20.64%
EPS Next 2Y17.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.66%
Revenue Next 2Y3.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
DHC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DHC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as DHC.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 15.24 |
4.3 Compensation for Growth
A more expensive valuation may be justified as DHC's earnings are expected to grow with 17.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.25%
EPS Next 3YN/A
5. Dividend
5.1 Amount
DHC has a yearly dividend return of 0.90%, which is pretty low.
Compared to an average industry Dividend Yield of 6.59, DHC's dividend is way lower than its industry peers. On top of this 92.97% of the companies listed in the same industry pay a better dividend than DHC!
Compared to an average S&P500 Dividend Yield of 2.41, DHC's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.9% |
5.2 History
The dividend of DHC decreases each year by -45.60%.
DHC has been paying a dividend for at least 10 years, so it has a reliable track record.
DHC has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-45.6%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
DHC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-2.74%
EPS Next 2Y17.25%
EPS Next 3YN/A
NASDAQ:DHC (11/25/2025, 11:29:06 AM)
4.725
+0.1 (+2.27%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners75.89%
Inst Owner Change-2.8%
Ins Owners0.48%
Ins Owner Change-8.52%
Market Cap1.14B
Revenue(TTM)1.54B
Net Income(TTM)-352.11M
Analysts48
Price Target5.36 (13.44%)
Short Float %2.53%
Short Ratio6.52
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.9% |
Yearly Dividend0.04
Dividend Growth(5Y)-45.6%
DP-2.74%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-142.08%
Min EPS beat(2)-213.15%
Max EPS beat(2)-71.02%
EPS beat(4)1
Avg EPS beat(4)-46.14%
Min EPS beat(4)-213.15%
Max EPS beat(4)122.5%
EPS beat(8)2
Avg EPS beat(8)-24.79%
EPS beat(12)4
Avg EPS beat(12)-9.26%
EPS beat(16)4
Avg EPS beat(16)-20.93%
Revenue beat(2)1
Avg Revenue beat(2)0.09%
Min Revenue beat(2)-0.49%
Max Revenue beat(2)0.67%
Revenue beat(4)2
Avg Revenue beat(4)0.37%
Min Revenue beat(4)-0.49%
Max Revenue beat(4)1.32%
Revenue beat(8)2
Avg Revenue beat(8)-0.49%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)5
Avg Revenue beat(16)-0.71%
PT rev (1m)23.53%
PT rev (3m)40%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.56%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.49%
Revenue NQ rev (1m)0.38%
Revenue NQ rev (3m)0.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.26%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.74 | ||
| P/FCF | N/A | ||
| P/OCF | 61.04 | ||
| P/B | 0.68 | ||
| P/tB | 0.68 | ||
| EV/EBITDA | 15.24 |
EPS(TTM)-1.37
EYN/A
EPS(NY)-0.66
Fwd EYN/A
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)0.08
OCFY1.64%
SpS6.37
BVpS7
TBVpS7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.52% | ||
| ROE | -20.85% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.58% | ||
| FCFM | N/A |
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
F-Score6
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.61 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 11.41 | ||
| Cap/Depr | 65.29% | ||
| Cap/Sales | 11.78% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 7.83% | ||
| Profit Quality | N/A | ||
| Current Ratio | 6.66 | ||
| Quick Ratio | 6.66 | ||
| Altman-Z | -0.31 |
F-Score6
WACC6.18%
ROIC/WACCN/A
Cap/Depr(3y)103.34%
Cap/Depr(5y)92.72%
Cap/Sales(3y)19.78%
Cap/Sales(5y)17.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3500%
EPS Next Y20.64%
EPS Next 2Y17.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.1%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%4.03%
Revenue Next Year3.66%
Revenue Next 2Y3.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y46.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year377.31%
EBIT Next 3Y72.02%
EBIT Next 5YN/A
FCF growth 1Y38.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.8%
OCF growth 3YN/A
OCF growth 5Y-15.84%
DIVERSIFIED HEALTHCARE TRUST / DHC FAQ
What is the fundamental rating for DHC stock?
ChartMill assigns a fundamental rating of 2 / 10 to DHC.
What is the valuation status for DHC stock?
ChartMill assigns a valuation rating of 1 / 10 to DIVERSIFIED HEALTHCARE TRUST (DHC). This can be considered as Overvalued.
How profitable is DIVERSIFIED HEALTHCARE TRUST (DHC) stock?
DIVERSIFIED HEALTHCARE TRUST (DHC) has a profitability rating of 1 / 10.
What is the expected EPS growth for DIVERSIFIED HEALTHCARE TRUST (DHC) stock?
The Earnings per Share (EPS) of DIVERSIFIED HEALTHCARE TRUST (DHC) is expected to grow by 20.64% in the next year.